Literature DB >> 24315995

Retracted: FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells.

Dewan Md Sakib Hossain1, Abir K Panda1, Argha Manna1, Suchismita Mohanty1, Pushpak Bhattacharjee1, Sankar Bhattacharyya1, Taniya Saha1, Sreeparna Chakraborty1, Rajiv K Kar2, Tanya Das1, Subhrangsu Chatterjee2, Gaurisankar Sa3.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the authors. This study provided an explanation for why loss of FoxP3 in inducible regulatory T cells results in reduced expression of interleukin (IL)-10 despite the absence of FoxP3 binding sites in the IL-10 promoter. STAT3 binding sites do exist in the promoter, and evidence for a direct molecular interaction between FoxP3 and STAT3 proteins was provided as an explanation of the effect of loss of FoxP3. As supporting evidence, we reported modeling of a structural interaction between these two transcription factors in Figure 4D. As the N-terminal region of FoxP3, which consists of the Exon-2 region, had not been solved at structural resolution, we mistakenly used what we deduced to be a FoxP3 related transcription factor, NFAT, in the modeling. The model depicted in Figure 4D therefore did not represent a putative interaction between FoxP3 and STAT3 as labeled, but rather a putative interaction between NFAT and STAT3. Given the incorrect labeling of Figure 4D, the lack of documentation in the paper describing exactly how the modeling was performed, the lack of evidence shown in the paper for the choice of NFAT as the modeling partner, and the limited supporting evidence for a cooperative interaction between FoxP3 and STAT3, the editors have concluded with the corresponding author that the appropriate course of action is to retract the paper. We apologize for any confusion and inconvenience caused to readers.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24315995     DOI: 10.1016/j.immuni.2013.11.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  57 in total

1.  STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Authors:  Chunyan Zhang; Chanyu Yue; Andreas Herrmann; Jieun Song; Colt Egelston; Tianyi Wang; Zhifang Zhang; Wenzhao Li; Heehyoung Lee; Maryam Aftabizadeh; Yi Jia Li; Peter P Lee; Stephen Forman; George Somlo; Peiguo Chu; Laura Kruper; Joanne Mortimer; Dave S B Hoon; Wendong Huang; Saul Priceman; Hua Yu
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

2.  Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.

Authors:  Xiaowei Chen; Yoshihiro Takemoto; Huan Deng; Moritz Middelhoff; Richard A Friedman; Timothy H Chu; Michael J Churchill; Yan Ma; Karan K Nagar; Yagnesh H Tailor; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

3.  Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity.

Authors:  Tiancen Hu; Jennifer E Yeh; Luca Pinello; Jaison Jacob; Srinivas Chakravarthy; Guo-Cheng Yuan; Rajiv Chopra; David A Frank
Journal:  Mol Cell Biol       Date:  2015-07-13       Impact factor: 4.272

4.  The aptamer-siRNA conjugates: reprogramming T cells for cancer therapy.

Authors:  Dewan Md Sakib Hossain; Priyanka Duttagupta; Marcin Kortylewski
Journal:  Ther Deliv       Date:  2015-01

5.  Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells.

Authors:  S Mukherjee; A Manna; P Bhattacharjee; M Mazumdar; S Saha; S Chakraborty; D Guha; A Adhikary; D Jana; M Gorain; S A Mukherjee; G C Kundu; D K Sarkar; T Das
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

6.  Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.

Authors:  David M Woods; Rupal Ramakrishnan; Andressa S Laino; Anders Berglund; Kelly Walton; Brian C Betts; Jeffrey S Weber
Journal:  Clin Cancer Res       Date:  2018-08-21       Impact factor: 12.531

Review 7.  Mechanisms and consequences of Jak-STAT signaling in the immune system.

Authors:  Alejandro V Villarino; Yuka Kanno; John J O'Shea
Journal:  Nat Immunol       Date:  2017-03-22       Impact factor: 25.606

8.  Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients.

Authors:  Kirti Kajal; Sayantan Bose; Abir K Panda; Dwaipayan Chakraborty; Sreeparna Chakraborty; Subhadip Pati; Tania Sarkar; Subhanki Dhar; Dia Roy; Shilpi Saha; Gaurisankar Sa
Journal:  Cancer Immunol Immunother       Date:  2021-01-04       Impact factor: 6.968

9.  Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.

Authors:  Ayman J Oweida; Adam C Mueller; Miles Piper; Dallin Milner; Benjamin Van Court; Shilpa Bhatia; Andy Phan; Thomas Bickett; Kimberly Jordan; Theresa Proia; Richard Schulick; Wells A Messersmith; Marco Del Chiaro; Eric Clambey; Michael J Gough; Jason Williams; Kirk Hansen; Karyn Goodman; Sana D Karam
Journal:  Cancer Immunol Immunother       Date:  2020-10-23       Impact factor: 6.968

Review 10.  Immunostimulatory biomaterials to boost tumor immunogenicity.

Authors:  Oluwaseyi T Shofolawe-Bakare; Larry D Stokes; Mehjabeen Hossain; Adam E Smith; Thomas A Werfel
Journal:  Biomater Sci       Date:  2020-09-02       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.